NON-MELANOMA SKIN CANCER (NMSC)
Clinical trials for NON-MELANOMA SKIN CANCER (NMSC) explained in plain language.
Never miss a new study
Get alerted when new NON-MELANOMA SKIN CANCER (NMSC) trials appear
Sign up with your email to follow new studies for NON-MELANOMA SKIN CANCER (NMSC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer-Killing virus combined with immunotherapy shows promise in advanced tumors
Disease control OngoingThis Phase 2 trial tests a genetically modified herpes virus (RP1) alone or with the immunotherapy drug nivolumab in people with advanced solid tumors, including melanoma, non-small cell lung cancer, and certain skin cancers. The study aims to see if the combination is safe and c…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Phase: PHASE2 • Sponsor: Replimune, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Danish study checks skin cancer patients years after radiation
Knowledge-focused ENROLLING_BY_INVITATIONThis study invites 2,900 adults who had radiotherapy for non-melanoma skin cancer on the head or neck between 2020 and 2024 to a follow-up visit at least two years later. Participants will fill out a questionnaire about how the treated area looks and have their skin examined. The…
Matched conditions: NON-MELANOMA SKIN CANCER (NMSC)
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC